Healthtech Startups

Awen Oncology is a drug discovery company developing first-in-class oncology therapeutics that target cancer-specific proteins found only in tumor cells, aiming for treatments with improved efficacy and fewer side effects. It combines high-throughput cell and molecular biology with computational techniques to identify novel therapeutic targets for cancer patients.

1 investor

Axcelead is a healthcare platform company with drug discovery as its core business, supporting pharmaceutical research for biotech ventures, pharmaceutical companies, and academic institutions. The company provides comprehensive drug discovery solutions leveraging advanced screening systems, compound libraries, and experienced researchers.

1 investor

Axel Health develops digital software for healthcare organizations to manage patient flow, including self-check-in, self-service payment, facility and resource planning, and patient transfers. Its tools serve hospitals, health centers, and clinical staff such as doctors, nurses, and therapists to shorten wait times and improve the patient experience in Finland.

1 investor

Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences. The company focuses on RNA therapeutics platform development and associated therapeutic programs.

1 investor

Axent Biosciences develops stem cell therapies to treat diseases like Parkinson's, using a proprietary cell cultivation platform to enable scalable and cost-effective manufacturing. The company was spun out of UC Berkeley research and aims to make stem cell therapies broadly accessible.

1 investor

Axial Orthopaedics is a medtech company in orthopedic healthcare, with leadership experienced in strategic exits.

1 investor

Axil Health provides integrated care management services and software for healthcare providers. The company deploys clinical teams (pharmacists, nurses, physician assistants) directly into medical practices alongside a technology platform to support chronic care management, remote patient monitoring, and value-based care delivery.

1 investor

Axio Biosolutions develops patented chitosan-based medical dressings for rapid bleeding control and wound care, aimed at managing severe bleeding and acute or chronic wounds. Its products target healthcare and emergency medical use with internationally certified technologies.

1 investor

Axiota develops an animal health platform focused on cattle products designed to help cattle thrive during transition and stress periods, serving cattle producers and consumers.

1 investor

Axis Spine Tech develops a modular ALIF (anterior lumbar interbody fusion) spinal implant system that lets surgeons intra-operatively select implant height and lordotic angle to achieve and maintain spinal alignment. The system is designed for spine surgeons, with endplate-protection technology intended to improve fusion and clinical outcomes.

1 investor

Axitare is a Finnish health technology company that develops an automated, cup-based medication dispenser with alarm for elderly people living at home, serving home care organisations and wellbeing services counties. Its device dispenses pre-portioned medicines in a cup without requiring users to open packaging or press buttons, and it operates in Finland and Denmark.

1 investor

Axogen develops surgical technologies and solutions for peripheral nerve repair procedures across various anatomical locations. The company serves surgical specialists and healthcare providers seeking to establish nerve function restoration as a standard treatment approach.

1 investor

Axon Health offers a care-coordination operating system that unifies client data from multiple systems into a single live record, with tools for intake, client records, bed and residence management, analytics, billing, and reporting. It appears aimed at residential care or social-service programs that manage client intakes, program phases, and bed assignments.

1 investor

Axon Therapies develops the SAVM procedure, an implant-free catheter-based ablation therapy that targets the right greater splanchnic nerve to reduce overactive sympathetic nerve activity in patients with heart failure with preserved ejection fraction (HFpEF). Its Axon Ablation Catheter is used in an outpatient procedure to block nerve signals and normalize volume balance.

1 investor

Axonic Health offers AxonHIS, a hospital information system with 50+ modules covering ER, OPD, IPD, OT, ICU, diagnostics, billing, inventory, and business intelligence workflows. It is built for hospitals and multi-specialty networks to manage end-to-end hospital operations.

1 investor

Axora Medical develops minimally invasive hysteroscopy solutions for gynecologists to diagnose and treat intrauterine conditions such as polyps and fibroids in both office and operating room settings.

1 investor

Ayamedica is a health records management platform for schools, clinics, and hospitals that enables secure sharing of medical information, digital consent, and health data management between patients, parents, and healthcare providers.

1 investor

AyuRythm offers body constitution assessment and health and wellness guidance through a smartphone-based, technology-enabled pulse-diagnosis method drawing on Ayurvedic principles. It targets individuals seeking personalized wellness advice.

1 investor

Ayuvant is developing an RNA-nanoparticle immunotherapy designed to direct the immune system to recognize and attack cancer cells. The platform targets patients who do not respond to existing immune checkpoint inhibitors and has shown antitumor activity in checkpoint-inhibitor-resistant models.

1 investor

Azevan Pharmaceuticals is a clinical-stage biopharmaceutical company developing orally bioavailable V1a receptor antagonists targeting vasopressin biology for neuropsychiatric, neurodegenerative, neurodevelopmental, and brain injury conditions. The company's lead candidate SRX246 has shown efficacy in reducing pathological aggression in Huntington's Disease and Intermittent Explosive Disorder.

1 investor

Azimuth Medical develops Air-Sequr, smart protective trousers embedded with sensors and an airbag system that automatically deploys upon fall detection to protect the hip. The wearable technology is designed for fall prevention and injury mitigation.

1 investor

AZ MediQuip is a retailer of home medical equipment and supplies that sells, rents, repairs, delivers, and installs equipment for seniors, families, and healthcare professionals. It operates retail showrooms across Arizona, USA.

1 investor

azulOptics develops eye-health screening technologies focused on prevention and early detection of eye disease. The company serves optometry providers and eye-care professionals with diagnostic instruments and related healthcare products.

1 investor

Azura Ophthalmics develops a new therapeutic class of ophthalmic keratolytics aimed at treating lid margin and ocular surface diseases and other underserved ophthalmic conditions. The company applies drug development expertise to address the core pathophysiology of these eye conditions.

1 investor